CoraLite® Plus 488-conjugated C1orf83 Recombinant antibody
C1orf83 Uni-rAbTM Recombinant Antibody for IF/ICC
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
IF/ICC
Conjugate
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
240678D10
验证数据展示
经过测试的应用
Positive IF/ICC detected in | HEK-293 cells |
For other applications, we recommend the unconjugated version of this antibody, 83626-3-PBS
推荐稀释比
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
The immunogen of CL488-83626-3 is C1orf83 Fusion Protein expressed in E. coli.
Tested Applications | IF/ICC Application Description |
Tested Reactivity | human |
Immunogen | C1orf83 fusion protein Ag15040 种属同源性预测 |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Full Name | chromosome 1 open reading frame 83 |
Synonyms | Transcription elongation factor A N-terminal and central domain-containing protein 2, TCEANC2, RP4 758J24.3, FLJ39169, FLJ32112 |
Calculated Molecular Weight | 208 aa, 23 kDa |
GenBank Accession Number | BC035374 |
Gene Symbol | C1orf83 |
Gene ID (NCBI) | 127428 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Protein A purification |
UNIPROT ID | Q96MN5 |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
C1orf83, also known as TCEANC2, and the rs10788972 variant of the TCEANC2 gene in the PARK10 region were identified as being strongly associated with sporadic PD in the US population.
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 C1orf83 antibody CL488-83626-3 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |